CENTRAL NEURAL REGULATION OF VASOPRESSIN SECRETION
CENTRAL NEURAL REGULATION OF VASOPRESSIN SECRETION
批准号:
3395162
负责人:
JAMES N HAYWARD
金额:
$15.42万
依托单位国家:
美国
项目类别:
财政年份:
1977
资助国家:
美国
项目状态:
已结题
起止时间:
1977-07-01 至 1991-03-31
关键词:
angiotensin II dopamine electron microscopy electrophysiology fresh water environment gamma aminobutyrate histochemistry /cytochemistry hormone regulation /control mechanism immunochemistry neural information processing neuroendocrine system neurotransmitters norepinephrine organ culture parasympathetic nervous system synapses vasopressins
中文摘要
我们的研究将集中在化学和生理因素上,
控制脑内大细胞神经元加压素的分泌
下丘脑视上核。这些因素将被识别出来,
并试图将这些与渗透性联系起来
对加压素分泌的调节。体外试验方法的应用
下丘脑-神经垂体复合体(HNC)将给出程度
实现这些目标所需的控制。HNC包含整个
视上-神经内分泌最终共同通路,包括两条完整的
视上核(NSO)、视上神经垂体束(SOHT)和
神经叶(NL)的神经分泌终末。每个主要站点
涉嫌参与加压素的渗透调节
HNC中存在分泌物。HNC外植体保持渗透敏感性
在体外,可以接近体内的响应性。因此,整个
功能通路的存在是为了探索功能
渗透刺激的整合和这一信息的传递
视上核的水平。我们将对发布的
加压素,并建立条件,使精确的时间和
通过SOHT对反应性进行半定量分析。的效果
将描述化学和渗透刺激及其相互作用
并将包括筛选各种假定的影响
神经递质对血管加压素(胆碱能、血管紧张素)释放的影响
去甲肾上腺素、脑啡肽、多巴胺)。尤其是,我们将重点关注
NSO的具体贡献,特别强调
尼古丁胆碱能系统被强烈地牵连在
控制加压素的分泌。推定烟碱的定位
NSO内含加压素的大细胞神经元上的受体将是
检查过了。将进行平行实验以评估特定的特性
这些受体可能与NSO的渗透敏感性有关。
经鉴定的细胞的电生理特性研究
NSO在化学和渗透挑战期间将提供详细的
生理反应与药物释放的时间比较
加压素。伴随而来的双重和三重标记程序
染色的神经元将用于细胞构筑重建和
三叉神经节突触传入的电子显微镜分析
免疫细胞化学鉴定NSO内的神经元。因此,HNC外植体
代表了一种简单、可行、高度受控的哺乳动物神经系统
哪些未知的生理过程表达了它们对井的影响
已确定的最终路径。理想的神经内分泌控制系统。
英文摘要
Our studies will focus on the chemical and physiological factors which
control the secretion of vasopressin by magnocellular neurons in the
hypothalamic supraoptic nucleus. These factors will be identified,
characterized and an attempt will be made to relate these to the osmotic
regulation of vasopressin secretion. The use of an in vitro approach with
the hypothalamo-neurohypophysial complex (HNC) will give the degree of
control necessary to achieve these goals. The HNC contains the entire
supraoptic-neuroendocrine final common pathway including the two intact
supraoptic nuclei (NSO), the supraoptico-neurohypophysial tract (SOHT) and
the neurosecretory terminals of the neural lobe (NL). Every major site
suspected of being involved in the osmotic regulation of vasopressin
secretion is present in the HNC. The HNC explant retains osmosensitivity
in vitro and can approach in vivo responsiveness. Thus, the entire
functional pathway is present for the exploration of the functional
integration of osmotic stimuli and the transduction of this information at
the level of the supraoptic nucleus. We will characterize the release of
vasopressin and establish the conditions which allow precise temporal and
semi-quantitative analys of responsiveness via the SOHT. Effects of
chemical and osmotic stimuli and their interactions will be characterized
and will include screening for the effects of various putative
neurotransmitters on the release of vasopressin (cholinergic, angiotensin
II, norepinephrine, enkephalin, dopamine). In particular, we will focus on
the specific contribution of the NSO with particular emphasis on the
nicotinic cholinergic system which has been strongly implicated in the
control of vasopressin secretion. The localization of putative nicotinic
receptors on vasopressin-containing magnocellular neurons in NSO will be
examined. Parallel experiments will be run to assess specific properties
of these receptors which may contribute to osmotic sensitivity of the NSO.
Investigation of the electrophysiological properties of identified cells in
the NSO during chemical and osmotic challenges will provide detailed
temporal comparison of the physiological responses with the release of
vasopressin. Concomitant double- and triple-labeling procedures on
dye-marked neurons will be used for cytoarchitectonic reconstruction and
electron microscopic analysis of synaptic inputs on
immunocytochemically-identified neurons in the NSO. Thus, the HNC explant
represents a simple, viable, highly controlled mammalian neural system in
which unknown physiological processes express their effects on a well
defined final pathway. Ideal neuroendocrine control system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CENTRAL NEURAL REGULATION OF VASOPRESSIN SECRETION
-
批准号:3395167
-
项目类别:
-
资助金额:$17.28万
-
财政年份:1977
-
负责人:JAMES N HAYWARD
-
依托单位:
CENTRAL NEURAL REGULATION OF VASOPRESSIN SECRETION
-
批准号:3395163
-
项目类别:
-
资助金额:$15.59万
-
财政年份:1977
-
负责人:JAMES N HAYWARD
-
依托单位:
EXCITATORY AMINO ACID REGULATION OF VASOPRESSIN CELLS
-
批准号:2262532
-
项目类别:
-
资助金额:$19.06万
-
财政年份:1977
-
负责人:JAMES N HAYWARD
-
依托单位:
CENTRAL NEURAL REGULATION OF VASOPRESSIN SECRETION
-
批准号:3395165
-
项目类别:
-
资助金额:$17.1万
-
财政年份:1977
-
负责人:JAMES N HAYWARD
-
依托单位:
EXCITATORY AMINO ACID REGULATION OF VASOPRESSIN CELLS
-
批准号:3395161
-
项目类别:
-
资助金额:$18.62万
-
财政年份:1977
-
负责人:JAMES N HAYWARD
-
依托单位:
CENTRAL NEURAL REGULATION OF VASOPRESSIN SECRETION
-
批准号:3395164
-
项目类别:
-
资助金额:$17.38万
-
财政年份:1977
-
负责人:JAMES N HAYWARD
-
依托单位:
CENTRAL NEURAL REGULATION OF VASOPRESSIN SECRETION
-
批准号:3395166
-
项目类别:
-
资助金额:$17.28万
-
财政年份:1977
-
负责人:JAMES N HAYWARD
-
依托单位:
国内基金
海外基金
登录
查看更多内容
DRD2/ERK/β-catenin信号联合Dopamine/ERK/TH调节环介导慢性应激促进脑胶质瘤恶性进展的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:周秀萍
-
依托单位:
11C-N-CH3-Dopamine PET/MRI心脏神经显像对射血分数保留的心衰的实验研究
-
批准号:82171969
-
项目类别:面上项目
-
资助金额:56万元
-
批准年份:2021
-
负责人:王雪梅
-
依托单位:
11C-N-CH3-Dopamine心肌Micro PET/CT显像对糖尿病心脏自主神经病变的评估
-
批准号:82060323
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2020
-
负责人:何玉林
-
依托单位:
11C-N-CH3-Dopamine神经显像对心肌"缺血记忆"的实验研究
-
批准号:81460271
-
项目类别:地区科学基金项目
-
资助金额:46.0万元
-
批准年份:2014
-
负责人:王雪梅
-
依托单位:
11C-dopamine PET/CT显像对急性心肌缺血状况下交感神经功能变化的实验研究
-
批准号:81060019
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:王雪梅
-
依托单位: